Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels: A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2158-2169

  Folli, Franco ^a   Kahn, C Ronald ^b   Hansen, Hans ^b   Bouchie, Julie L ^b   Feener, Edward P ^b,c  

^a Divisione Malattie Metaboliche   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

Angiotensin II; Insulin receptor substrate 1; Insulin resistance; Phosphatidylinositol 3 kinase; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

AORTA MEDIA; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE COMPLEX; HORMONAL REGULATION; HUMAN CELL; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

EID: 0030723979     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119752     Document Type: Article

References (71)

1. Dzau, V.J. 1994. Cell biology and genetics of angiotensin in cardiovascular disease. J. Hypertens. 12(suppl):S3-S10.
2. Regitz-Zagrosek, V., M. Neub, and J. Holzmeister. 1996. Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J. Mol. Med. 74:233-251.
3. Diet, F., R.E. Pratt, G.J. Berry, N. Momose, G.H. Gibbons, and V.J. Dzau. 1996. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 94:2756-2767.
4. Rakugi, H., H.J. Jacob, J.E. Krieger, J.R. Ingelfinger, and R.E. Pratt. 1993. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 87:283-290.
5. Rakugi, H., D.K. Kim, J.E. Krieger, D.S. Wang, V.J. Dzau, and R.E. Pratt. 1994. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J. Clin. Invest. 93:339-346.
6. Daemen, M.J.A.P., D.M. Lombardi, F.T. Bosman, and S.M. Schwartz. 1991. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ. Res. 68:450-456.
7. Hamdan, A.D., W.C. Quist, J.B. Gagne, and E.P. Feener. 1996. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Circulation. 93: 1073-1078.
8. Kim, S., M. Kawamura, H. Wanibuchi, K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, and H. Iwao. 1995. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation. 92:88-95.
9. Powell, J.S., J.-P. Clozel, R.K.M. Muller, H. Kuhn, F. Hefti, M. Hosang, and H.R. Baumgartner. 1989. Inhibitors of angiotensin converting enzyme prevent myointimal proliferation after vascular injury. Science (Wash. DC). 245: 186-188.
10. Garg, R., and S. Yusef. 1995. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA (J. Am. Med. Assoc.). 273:1450-1456.
11. MERCATOR Study Group. 1992. Does the new angiotensin-converting-enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double blind placebo-controlled trial. Circulation. 86:100-110.
12. Torlone, E., M. Britta, A.M. Rambotti, G. Perriello, F. Santeusanio, P. Brunetti, and G.B. Bolli. 1993. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Diabetes Care. 16:1347-1355.
13. Shieh, S., D. Shen, W.H.H. Sheu, M. Fuh, C.Y. Jeng, J.R. Jeng, Y.I. Chen, and G.M. Reaven. 1992. Improvement in metabolic risk factors for coronary heart disease associated with cilazapril treatment. Am. J. Hypertens. 5: 506-510.
14. Raccah, D., M. Pettenuzzo-Mollo, O. Provendier, L. Boucher, J.A. Cozic,. R. Gorlier, P. Huin, J. Sicard, and P. Vague. 1994. Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. Am. J. Hypertens. 7:731-738.
15. Howard, G., D.H. O'Leary, D. Zaccaro, S. Haffner, M. Rewers, R. Hamman, J.V. Selby, M.F. Saad, P. Savage, R. Bergman, and IRAS Investigators. 1996. Insulin sensitivity and atheroselerosis. Circulation. 93:1809-1817.
16. Haffner, S.M., M. P. Stern, H.P. Hazuda, B.D. Mitchell, and J.K. Patterson. 1990. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA (J. Am. Med. Assoc.). 263:2893-2898.
17. Ferrannini, E., G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317:350-357.
18. Zavaroni, I., E. Bonora, M. Pagliara, E. Dall'Aglio, L. Luchetti, G. Buonanno, P.A. Bonati, M. Bergonzani, L. Gnudi, M. Passeri, et al. 1989. Risk factors for coronary artery diease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med. 320:702-706.
19. Murphy, T.J., R.W. Alexander, K.K. Griendling, M.S. Runge, and K.E. Bernstein. 1991. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond.). 351:233-236.
20. Dixon, B.S., R.V. Sharma, T. Dickerson, and J. Fortune. 1994. Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am. J. Physiol. 266:C1406-C1420.
21. Marrero, M.B., B. Schieffer, W.G. Paxton, I. Heerdt, B.C. Berk, P. Delafontaine, and K.E. Bernstein. 1995. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature (Lond.). 375:247-250.
22. Schorb, W., T.C. Peeler, N.N. Madigan, K.M. Conrad, and K.M. Baker. 1994. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J. Biol. Chem. 269:19626-19632.
23. Feener, E.P., J.M. Northrup, L.P. Aiello, and G.L. King. 1995. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J. Clin. Invest. 95:1353-1362.
24. Bell, L., D.J. Luthringer, J.A. Madri, and S.L. Warren. 1992. Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression. J. Clin. Invest. 89:315-320.
25. Weber, H., D.S. Taylor, and C.J. Molloy. 1994. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. J. Clin. Invest. 93:788-798.
26. Daub, H., F.U. Weiss, C. Wallasch, and A. Ullrich. 1996. Role of transactivation of the EOF receptor in signalling by G protein-coupled receptors. Nature (Lond.). 379:557-560.
27. Linseman, D.A., C.W. Benjamin, and D.A. Jones. 1995. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J. Biol. Chem. 270:12563-12568.
28. Saad, M.J.A., L.A. Velloso, and C.R.O. Carvalho. 1995. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem. J. 310:741-744.
29. Velloso, L.A., F. Folli, X.J. Sun, M.F. White, M.J.A. Saad, and C.R. Kahn. 1996. Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. USA. 93:12490-12495.
30. White, M.F., and C.R. Kahn. 1994. The insulin signaling system. J. Biol. Chem. 269:1-4.
31. Eck, M.J., S. Dhe-Paganon, T. Trub, R.T. Nolte, and S.E. Shoelson. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell. 85:695-705.
32. Sun, X.J., L. Wang, Y. Zhang, L. Yenush, M.G. Myers, Jr., E. Glasheen, W.S. Lane, J.H. Pierce, and M.F. White. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature (Lond.). 377:173-177.
33. Sun, X.J., P. Rotheenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (Lond.). 352:73-77.
34. Folli, F., M.J. Saad, J.M. Backer, and C.R. Kahn. 1992. Insulin stimulation of phosphalidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle on the intact rat. J. Biol. Chem. 267:22171-22177.
35. Sun, X.J., S. Pons, T. Asano, M.G. Myers, Jr., E. Glasheen, and M.F. White. 1996. The Fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271:10583-10587.
36. Kelly, K.L., and N.B. Ruderman. 1993. Insulin-stimulated phosphatidylinositol 3-kinase. J. Biol. Chem. 268:4391-4398.
37. Backer, J.M., M.G. Myers, Jr., S.E. Shoelson, D.J. Chin, X.-J. Sun, M. Miralpeix, P. Hu, B. Margolis, E.Y. Skolnik, J. Schlessinger, and M.F. White. 1992. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO (Eur. Mol. Biol. Organ.) J. 11:3469-3479.
38. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172-1179.
39. Scherrer, U., D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94:2511-2515.
40. Feener, E.P., J.M. Backer, G.L. King, P.A. Wilden, X.J. Sun, C.R. Kahn, and M.F. White. 1993. Insulin stimulales serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J. Biol. Chem. 268:11256-11264.
41. Wolf, G., T. Trub, E. Ottinger, L. Groninga, A. Lynch, M.F. White, M. Miyazaki, J. Lee, and S.E. Shoelson. 1995. PTB domains of IRS-1 and she have distinct but overlapping binding specificities. J. Biol. Chem. 270:27407-27410.
42. Eguchi, S., T. Matsumoto, E.D. Motley, H. Utsunomiya, and T. Inagami. 1996. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J. Biol. Chem. 274:14169-14175.
43. Tanti, J., T. Gremeaux, E. Van Obberghen, and Y. Le Marchand-Brustel. 1994. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269:6051-6057.
44. Mothe, I., and E. Van Obberghen. 1996. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271:11222-11227.
45. Takayama, S., M.F. White, and C.R. Kahn. 1988. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J. Biol. Chem. 263:3440-3447.
46. Hotamisligil, G.S., P. Peraldi, A. Budavari, R. Ellis, M.F. White, and B.M. Spiegelman. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science (Wash. DC). 271:665-668.
47. Pillay, T.S., S. Xiao, and J.M. Olefsky. 1996. Glucose-induced phosphorylation of the insulin receptor. J. Clin. Invest. 97:613-620.
48. White, M.F., J.N. Livingston, J.M. Backer, V. Lauris, T.J. Dull, A. Ullrich, and C.R. Kahn. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell. 54: 641-649.
49. Dhand, R., I. Hiles, G. Panayotou, S. Roche, M.J. Fry, I. Gout, N.F. Totty, O. Truong, P. Vicendo, K. Yonezawa, et al. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO (Eur. Mol. Biol. Organ.) J. 13:522-533.
50. Carpenter, C.L., K.R. Auger, B.C. Duckworth, W.M. Hou, B. Schaffhausen, and L.C. Cantley. 1993. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol. 13:1657-1665.
51. Tanti, J., T. Gremeaux, E. Van Obbergen, and Y. Le Marchand-Brustel. 1994. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem. J. 304:17-21.
52. Lam, K., C.L. Carpenter, N.B. Ruderman, J.C. Friel, and K.L. Kelley. 1994. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-I. Stimulation by insulin and inhibition by Wortmannin. J. Biol. Chem. 269:20648-20652.
53. Rameh, L.E., C. Chen, and L.C. Cantley. 1995. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell. 83:821-830.
54. Antonetti, D.A., P. Algenstaedt, and C.R. Kahn. 1996. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell. Biol. 16:2195-2203.
55. Inukai, K., M. Anai, E. Van Breda, T. Hosaka, H. Katagiri, M. Funaki, Y. Fukushima, T. Ogihara, Y. Yazaki, M. Kikuchi, et al. 1996. A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85α gene. J. Biol. Chem. 271:5317-5320.
56. Klippel, A., J.A. Escobedo, W.J. Fantl, and L.T. Williams. 1992. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidyinositol 3-kinase to phosphorylated platelet-derived growth factor β receptor. Mol. Cell. Biol. 12:1451-1459.
57. Stoyanov, B., S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S. Stoyanova, B. Vanhaesebroeck, R. Dhand, B. Nurnberg, et al. 1995. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science (Wash. DC). 269:690-693.
58. Wan, Y., T. Kurosaki, and X.-Y. Huang. 1996. Tyrosine kinases in activation of the MAP kinase cascade by G protein-coupled receptors. Nature (Lond.). 380:541-544.
59. Jawien, A., D.F. Bowen-Pope, V. Lindner, S.M. Schwartz, and A.W. Clowes. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:507-511.
60. Ridray, S., D. Heudes, O. Michel, L. Penicaud, and A. Ktorza. 1994. Increased SMC proliferation after endothelial injury in hyperinsulinemic obese Zucker rats. Am. J. Physiol. 267:H1976-H1983.
61. Caro, J.F., O. Ittoop, W.J. Pories, D. Meelheim, E.G. Flickinger, F. Thomas, M. Jenquin, J.F. Silverman, P.G. Khazanie, and M.K. Sinha. 1986. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J. Clin. Invest. 78:249-258.
62. Folli, F., M.J. Saad, J.M. Backer, and C.R. Kahn. 1993. Regulation of the phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J. Clin. Invest. 92: 1787-1794.
63. Duff, J.L., M.B. Marrero, W.G. Paxton, C.H. Charles, L.F. Lau, K.E. Bernstein, and B.C. Berk. 1993. Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells. J. Biol. Chem. 268: 26037-26040.
64. Myers, M.G., Jr., and M.F. White. 1996. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36:615-658.
65. Banskota, N.K., R. Taub, K. Zellner, P. Olsen, and G.L. King. 1989. Characterization of the induction of proto-oncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-1. Diabetes. 38:123-129.
66. Zeng, G., and M.J. Quon. 1996. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J. Clin. Invest. 98:894-898.
67. Cheatham, B., C.J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C.R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911.
68. Chung, J., T.C. Grammer, K.P. Lemon, A. Kazlauskas, and J. Blenis. 1994. PDGF-and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature (Lond.). 370:71-75.
69. Araki, E., M.A. Lipes, M.E. Patti, J.C. Bruning, B. Haag 3rd, R.S. Johnson, and C.R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature (Lond.). 372:186-190.
70. Tamemoto, H., T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature (Lond.). 372:182-186.
71. Rose, D.W., A.R. Saltiel, M. Majumdar, S.J. Decker, J.M. Olefsky. 1994. Insulin receptor substrate-1 is required for insulin mediated mitogenesis signal transduction. Proc. Natl. Acad. Sci. USA. 91:797-801.